United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $773,721,457.77
Most recent insider trade:
  • Nov. 11, 2024
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 21, 2022CEO8,000$266.93Sell$2,135,440.00
Nov. 18, 2022CEO8,000$263.97Sell$2,111,760.00
Nov. 14, 2022CEO8,000$258.17Sell$2,065,360.00
Nov. 8, 2022CEO7,680$262.70Sell$2,017,536.00
Nov. 7, 2022Director290$268.57Sell$77,885.30
Nov. 4, 2022CEO8,000$264.85Sell$2,118,800.00
Nov. 3, 2022EVP6,000$257.08Sell$1,542,480.00
Nov. 1, 2022Director700$230.28Sell$161,196.00
Oct. 20, 2022EVP6,000$216.68Sell$1,300,080.00
Oct. 6, 2022EVP6,000$209.26Sell$1,255,560.00
Oct. 3, 2022Director710$211.56Sell$150,207.60
Sept. 28, 2022Director850$211.05Sell$179,392.50
Sept. 22, 2022EVP6,000$203.34Sell$1,220,040.00
Aug. 23, 2022Director3,500$224.96Sell$787,360.00
Aug. 4, 2022EVP4,552$225.81Sell$1,027,887.12
July 21, 2022EVP6,000$226.27Sell$1,357,620.00
July 11, 2022N/A2,160$241.29Sell$521,186.40
July 11, 2022Director2,160$241.29Sell$521,186.40
July 7, 2022EVP6,000$242.04Sell$1,452,240.00
July 7, 2022EVP & GENERAL COUNSEL1,900$240.46Sell$456,874.00
June 27, 2022Director5,000$236.79Sell$1,183,950.00
June 16, 2022EVP6,000$215.58Sell$1,293,480.00
May 31, 2022CEO3,000$230.85Sell$692,550.00
May 27, 2022CEO3,000$231.27Sell$693,810.00
May 26, 2022Director5,000$223.54Sell$1,117,700.00
May 25, 2022CEO3,000$223.58Sell$670,740.00
May 23, 2022CEO3,000$209.61Sell$628,830.00
May 19, 2022EVP6,000$183.43Sell$1,100,580.00
May 5, 2022EVP6,000$190.65Sell$1,143,900.00
April 21, 2022EVP6,000$189.18Sell$1,135,080.00
April 7, 2022EVP6,000$185.52Sell$1,113,120.00
March 17, 2022EVP6,000$182.42Sell$1,094,520.00
March 3, 2022EVP6,000$174.12Sell$1,044,720.00
Feb. 17, 2022EVP6,000$202.17Sell$1,213,020.00
Feb. 3, 2022EVP6,000$200.10Sell$1,200,600.00
Jan. 20, 2022EVP6,000$205.57Sell$1,233,420.00
Jan. 6, 2022EVP6,000$192.46Sell$1,154,760.00
Dec. 29, 2021CEO3,082$212.49Sell$654,894.18
Dec. 27, 2021CEO3,082$213.31Sell$657,421.42
Dec. 22, 2021CEO3,082$202.44Sell$623,920.08
Dec. 20, 2021CEO3,082$200.00Sell$616,400.00
Dec. 16, 2021EVP6,000$195.53Sell$1,173,180.00
Dec. 2, 2021EVP6,000$189.36Sell$1,136,160.00
Nov. 24, 2021CEO3,083$200.64Sell$618,573.12
Nov. 22, 2021CEO3,083$200.42Sell$617,894.86
Nov. 15, 2021CEO3,083$203.45Sell$627,236.35
Nov. 10, 2021CEO3,083$200.00Sell$616,600.00
Nov. 8, 2021CEO3,083$200.94Sell$619,498.02
Nov. 8, 2021Director2,300$200.16Sell$460,368.00
Nov. 4, 2021CEO3,083$200.00Sell$616,600.00
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.